Sensei Biotherapeutics Inc (SNSE)
0.5555
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
0.5438
-0.01
(-2.11%)
After-Hours: 20:00
Sensei Biotherapeutics Cash from Financing (Quarterly): -0.18M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.18M |
| March 31, 2024 | -0.209M |
| December 31, 2023 | -0.431M |
| September 30, 2023 | -2.534M |
| June 30, 2023 | -7.946M |
| March 31, 2023 | -0.262M |
| December 31, 2022 | -0.124M |
| September 30, 2022 | -0.163M |
| June 30, 2022 | -0.119M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.119M |
| December 31, 2021 | -0.118M |
| September 30, 2021 | -0.007M |
| June 30, 2021 | -0.011M |
| March 31, 2021 | 164.08M |
| December 31, 2020 | 15.86M |
| September 30, 2020 | 8.481M |
| June 30, 2020 | 0.556M |
| March 31, 2020 | 10.56M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-7.946M
Minimum
Jun 2023
164.08M
Maximum
Mar 2021
10.42M
Average
-0.1185M
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 12.99M |
| Theriva Biologics Inc | 1.773M |
| Oragenics Inc | 0.8212M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.792M |
| Cash from Investing (Quarterly) | 6.907M |
| Free Cash Flow | -24.38M |
| Free Cash Flow Per Share (Quarterly) | -0.2351 |
| Free Cash Flow Yield | -174.4% |